相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model
Oliver Ibarrondo et al.
GACETA SANITARIA (2020)
Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
Quang A. Le et al.
ANNALS OF PHARMACOTHERAPY (2019)
Barriers and Facilitators to Model Replication Within Health Economics
Emma McManus et al.
VALUE IN HEALTH (2019)
Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma
Ahmad Tarhini et al.
IMMUNOTHERAPY (2019)
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Gian Luca Di Tanna et al.
PHARMACOECONOMICS (2019)
Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine
Martine Hoogendoorn et al.
VALUE IN HEALTH (2019)
Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system
Mary Geitona et al.
JOURNAL OF MEDICAL ECONOMICS (2019)
Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime
Fangfang Jiao et al.
ENDOCRINE (2019)
A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data
Han-I Wang et al.
VALUE IN HEALTH (2018)
When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing-remitting multiple sclerosis
Kathleen Mary Noon et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis
Ahmad Tarhini et al.
IMMUNOTHERAPY (2018)
Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients
Koen Degeling et al.
CANCER EPIDEMIOLOGY (2018)
Economic Evaluation of an Integrated Health and Social Care Program for Heart Failure Through 2 Different Modeling Techniques
Igor Larranaga et al.
HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY (2018)
A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models
Koen Degeling et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease
Zafar Zafari et al.
VALUE IN HEALTH (2017)
The Prime Diabetes Model: Novel Methods for Estimating Long-Term Clinical and Cost Outcomes in Type 1 Diabetes Mellitus
William J. Valentine et al.
VALUE IN HEALTH (2017)
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review
Irmgard C. Schiller-Fruethwirth et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2017)
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus
Martin Henriksson et al.
PHARMACOECONOMICS (2016)
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)
Roland Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation
Stuart W. Grant et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
Dawn Lee et al.
HEART (2014)
Not Simply More of the Same: Distinguishing between Patient Heterogeneity and Parameter Uncertainty
Pepijn Vemer et al.
MEDICAL DECISION MAKING (2014)
Treadmill Endurance During 2-Year Treatment With Tiotropium in Patients With COPD A Randomized Trial
Christopher B. Cooper et al.
CHEST (2013)
Tiotropium Respimat Inhaler and the Risk of Death in COPD
Robert A. Wise et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope
W. Ken Redekop et al.
VALUE IN HEALTH (2013)
Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
J. M. Burr et al.
HEALTH TECHNOLOGY ASSESSMENT (2012)
Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
J. Jaime Caro et al.
MEDICAL DECISION MAKING (2012)
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
Andrew H. Briggs et al.
VALUE IN HEALTH (2012)
Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
Jonathan Karnon et al.
VALUE IN HEALTH (2012)
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Claus Vogelmeier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Uncertainty and Patient Heterogeneity in Medical Decision Models
Bas Groot Koerkamp et al.
MEDICAL DECISION MAKING (2010)
Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?
Jaime J. Caro et al.
VALUE IN HEALTH (2010)
Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis
E. L. Simpson et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modelling methods for pharmacoeconomics and health technology assessment - An overview and guide
James E. Stahl
PHARMACOECONOMICS (2008)
A taxonomy of model structures for economic evaluation of health technologies
Alan Brennan et al.
HEALTH ECONOMICS (2006)
Development and validation, of the economic assessment of glycemic control and long-term effects of diabetes (EAGLE) model
Elvira Mueller et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2006)
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial:: A US perspective of the MERIT-HF trial
JJ Caro et al.
JOURNAL OF CARDIAC FAILURE (2005)
分享论文
